Search results

  1. Peter T

    Lightning Process study in Norway - Given Ethics Approval February 2022

    Always good to see researchers taking the randomised aspect of ‘randomised controlled studies’ seriously (not).
  2. Peter T

    Trial Report Fatigue, CFS and migraine: Intersecting the lines through a cross-sectional study in patients with episodic and chronic migraine, 2023, Kumar

    Also it is a complex issue teasing apart migraines as a symptom of ME and migraines co occurring with ME. I get migraines when in PEM and I see them as a symptom of the PEM, their frequency, duration and severity are associated with the current severity of my overall ME. However I also get...
  3. Peter T

    UK - The Young ME Sufferers (TYMES) Trust

    I hope they are still going as support for families facing inappropriate child protection enforcement when professionals refuse to believe in the reality of ME is so vitally important. At least with the new NICE guidelines it should be easier in theory for parents to refuse GET here in the UK...
  4. Peter T

    Petition: S4ME 2023 - Cochrane: Withdraw the harmful 2019 Exercise therapy for CFS review

    Great to see the numbers signing this petition. Also the comments added strike me as particularly powerful in their sheer number, hammering home the issues of PEM and that exercise therapies harm. Does change.org display the number of comments anywhere?
  5. Peter T

    Petition: S4ME 2023 - Cochrane: Withdraw the harmful 2019 Exercise therapy for CFS review

    My understanding is that the letter has already been sent in order to reach Cochrane before their September meeting, though people can email S4ME if they want their name added to the online version. Presumably we will present the petition separately to Cochrane at a later date in order to...
  6. Peter T

    Phantoms in the Brain - BBC radio programme on 'Functional Neurological Disorder'

    Worse it is treated as definitively ruling in a psychosomatic cause.
  7. Peter T

    Independent advisory group for the full update of the Cochrane review on exercise therapy and ME/CFS (2020), led by Hilda Bastian

    Though it is interesting to ask how effective is Cochrane as an organisation, and how dependent is the review process on authors misusing the review process to promote their own vested interests through biased reporting, I am not sure S4ME should be analysing in any depth reviews that are not...
  8. Peter T

    Review A Scoping Review of Pacing for Management of [ME/CFS]: Lessons Learned for the Long COVID Pandemic, 2023, Sanal-Hayes et al

    Not looked at the article yet, but any thing that risks patients or clinicians seeing ‘pacing’ as a treatment rather than a way to try to avoid PEM and deterioration in ME is dangerous. It may possibly be that good pacing can create better conditions for some degree of spontaneous improvement...
  9. Peter T

    Treatment and outcomes of 95 post-Covid patients with an antidepressant and neurobiological explanations, 2023, Rus et al

    It is reminiscent of the idea in the 1990s that Prozac could treat ME. If my memory serves my correctly some doctors got very enthusiastic, but when proper controls were used it had no effect.
  10. Peter T

    Functional Overlay Model of Persistent Post-Concussion Syndrome, 2023, Mavroudis et al

    My first thought on reading the abstract is that the argument for a functional overlay in PPCS are logically in the realm of homeopathy’s doctrine of similars.
  11. Peter T

    What items/documents would you like to send to GPs/primary care physicians if you were doing a mail-out?

    We lack any reasonable evidence that appropriate psychological support is helpful in managing psychological distress specifically associated with having ME/CFS, though we can say on the basis of the published research that CBT aimed at treating/curing ME/CFS is at best ineffective and for some...
  12. Peter T

    Closed UK: DecodeME updates, was recruitment thread.

    Last Friday I got my spit kit in the as part of the new wave under the extended criteria. Got it sent back yesterday, when my PA was here to post it.
  13. Peter T

    Contesting the psychiatric framing of ME/CFS, 2017, Spandler and Allen

    You don’t even have to compare to other conditions for people that have fluctuation and relapsing and remitting ME. Over the thirty years of my ME I have had periods of quite dramatic improvement: indeed after the first four years or so, I believed myself recovered for several years up to a...
  14. Peter T

    News from Germany

    So deeply frustrating. (If ‘decimate’ literally means reduce by ten percent, what would reduce by eighty percent be?)
  15. Peter T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    A tangent to this thread, but did anyone ever manage to access the PACE data from the sharing platform where it was supposedly accessible. [added - see our thread on the PACE trial data https://www.s4me.info/threads/pace-trial-data.2337/page-9#post-483591 though it seems no one has reported...
  16. Peter T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    In this context would it be appropriate to raise with NHS England and the Health Minister that, in addition to concerns about Sir Simon Wessely’s appointment as a non-executive board member when he is co-authoring an attack on NICE, could they also confirm if he is or is not the senior health...
  17. Peter T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Though it is still early days and despite their prior 20 years of champion the BPS approach to CFS, they do seem to have taken a more balanced view of the condition and don’t now just take their expert opinions from the same narrow group of vested interests. Since their round up of the launch of...
  18. Peter T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    As has been said, how can it be that some of these people have treated people with ME, but understand so little about the condition? It must take an exceptional ego and an exceptional lack of intellectual curiosity to miss so much, both in terms of the academic debate and the lived experience...
  19. Peter T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    I think the Sonya Chowdhury/Action for ME letter is well pitched for a Newspaper context. I hope it gets published/posted. I look forward to the various more considered responses to the journal article too. I was wondering if the timing of the paper and the KCL press release was deliberate or...
  20. Peter T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    The long list of ‘after the fact authors’ illustrates that this is not a study or critique of an academic issue rather an assertion of a group’s opinion or beliefs.
Back
Top Bottom